BR112017011513A2 - tratamento de condições oculares usando células progenitoras - Google Patents
tratamento de condições oculares usando células progenitorasInfo
- Publication number
- BR112017011513A2 BR112017011513A2 BR112017011513A BR112017011513A BR112017011513A2 BR 112017011513 A2 BR112017011513 A2 BR 112017011513A2 BR 112017011513 A BR112017011513 A BR 112017011513A BR 112017011513 A BR112017011513 A BR 112017011513A BR 112017011513 A2 BR112017011513 A2 BR 112017011513A2
- Authority
- BR
- Brazil
- Prior art keywords
- progenitor cells
- treatment
- eye conditions
- cells
- neuronal
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 3
- 230000007514 neuronal growth Effects 0.000 abstract 2
- 210000000225 synapse Anatomy 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001143 conditioned effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000001228 trophic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- General Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pregnancy & Childbirth (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462088429P | 2014-12-05 | 2014-12-05 | |
| US201562126370P | 2015-02-27 | 2015-02-27 | |
| US201562220873P | 2015-09-18 | 2015-09-18 | |
| PCT/US2015/063923 WO2016090215A2 (en) | 2014-12-05 | 2015-12-04 | Treatment of ocular conditions using progenitor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017011513A2 true BR112017011513A2 (pt) | 2018-07-10 |
Family
ID=56092673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017011513A BR112017011513A2 (pt) | 2014-12-05 | 2015-12-04 | tratamento de condições oculares usando células progenitoras |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20160158293A1 (enExample) |
| EP (1) | EP3258946A4 (enExample) |
| JP (1) | JP2017537702A (enExample) |
| KR (1) | KR20170093178A (enExample) |
| CN (1) | CN107206028A (enExample) |
| AU (1) | AU2015358330A1 (enExample) |
| BR (1) | BR112017011513A2 (enExample) |
| CA (1) | CA2969690A1 (enExample) |
| HK (1) | HK1250329A1 (enExample) |
| MX (1) | MX2017007207A (enExample) |
| PH (1) | PH12017500998A1 (enExample) |
| RU (1) | RU2017123184A (enExample) |
| SG (1) | SG11201704268TA (enExample) |
| TW (1) | TW201636032A (enExample) |
| WO (1) | WO2016090215A2 (enExample) |
| ZA (1) | ZA201704521B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| WO2018102174A1 (en) * | 2016-12-01 | 2018-06-07 | Janssen Biotech, Inc. | Treatment of retinal degeneration using progenitor cells |
| GB201703058D0 (en) | 2017-02-24 | 2017-04-12 | Ucl Business Plc | Biomarkers |
| JP7348892B2 (ja) * | 2019-12-30 | 2023-09-21 | 佛教慈濟醫療財團法人 | 眼疾患を予防または治療する組成物及び方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004252571C1 (en) * | 2003-06-27 | 2012-03-01 | Ethicon, Incorporated | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| US8790637B2 (en) * | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| WO2010131917A2 (ko) * | 2009-05-13 | 2010-11-18 | 메디포스트(주) | 줄기세포의 세포 활성과 연관된 ｔｓｐ-1, ｔｓｐ-2, ｉｌ-17ｂｒ 및 ｈｂ-ｅｇｆ 및 이들의 용도 |
| KR101462004B1 (ko) * | 2011-07-11 | 2014-11-19 | (주)차바이오메드 | 탯줄 추출물의 제조방법 및 그의 용도 |
| US20130251670A1 (en) * | 2011-09-13 | 2013-09-26 | Aidan Products, Inc | Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof |
-
2015
- 2015-12-04 TW TW104140661A patent/TW201636032A/zh unknown
- 2015-12-04 MX MX2017007207A patent/MX2017007207A/es unknown
- 2015-12-04 US US14/960,055 patent/US20160158293A1/en not_active Abandoned
- 2015-12-04 BR BR112017011513A patent/BR112017011513A2/pt not_active Application Discontinuation
- 2015-12-04 KR KR1020177018057A patent/KR20170093178A/ko not_active Withdrawn
- 2015-12-04 AU AU2015358330A patent/AU2015358330A1/en not_active Abandoned
- 2015-12-04 EP EP15865014.3A patent/EP3258946A4/en not_active Withdrawn
- 2015-12-04 CA CA2969690A patent/CA2969690A1/en not_active Abandoned
- 2015-12-04 RU RU2017123184A patent/RU2017123184A/ru not_active Application Discontinuation
- 2015-12-04 WO PCT/US2015/063923 patent/WO2016090215A2/en not_active Ceased
- 2015-12-04 HK HK18108224.1A patent/HK1250329A1/zh unknown
- 2015-12-04 SG SG11201704268TA patent/SG11201704268TA/en unknown
- 2015-12-04 JP JP2017529751A patent/JP2017537702A/ja active Pending
- 2015-12-04 CN CN201580075547.0A patent/CN107206028A/zh active Pending
-
2017
- 2017-05-30 PH PH12017500998A patent/PH12017500998A1/en unknown
- 2017-07-04 ZA ZA2017/04521A patent/ZA201704521B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107206028A (zh) | 2017-09-26 |
| RU2017123184A (ru) | 2019-01-10 |
| SG11201704268TA (en) | 2017-06-29 |
| ZA201704521B (en) | 2019-01-30 |
| PH12017500998A1 (en) | 2017-12-18 |
| MX2017007207A (es) | 2018-01-30 |
| TW201636032A (zh) | 2016-10-16 |
| WO2016090215A2 (en) | 2016-06-09 |
| AU2015358330A1 (en) | 2017-06-08 |
| CA2969690A1 (en) | 2016-06-09 |
| HK1250329A1 (zh) | 2018-12-14 |
| EP3258946A4 (en) | 2018-08-01 |
| JP2017537702A (ja) | 2017-12-21 |
| RU2017123184A3 (enExample) | 2019-07-17 |
| KR20170093178A (ko) | 2017-08-14 |
| US20160158293A1 (en) | 2016-06-09 |
| EP3258946A2 (en) | 2017-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015148863A3 (en) | Crispr/cas-related methods and compositions for treating sickle cell disease | |
| MX2021006581A (es) | Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia. | |
| MX389789B (es) | Moléculas del receptor de envolvimiento quimérico. | |
| EA201891192A1 (ru) | Средства и способы лечения миопатий, связанных с титином, и других титинопатий | |
| GT201400162A (es) | Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas | |
| WO2016037157A3 (en) | Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies | |
| HK1252568A1 (zh) | 一种治疗方法 | |
| BR112017005598A2 (pt) | macrociclos peptidomiméticos e usos dos mesmos | |
| CL2017001301A1 (es) | Composiciones oftálmicas estabilizadas de omega 3 | |
| MX2020011415A (es) | Metodos de usar zscan4 para rejuvenecer celulas humanas. | |
| EA201890442A1 (ru) | Получение фоторецепторов для лечения заболеваний сетчатки | |
| BR112017012581A2 (pt) | tratamento de degeneração da retina com o uso de células progenitoras | |
| EP4484443A3 (en) | Materials and methods for treatment of friedreich ataxia and other related disorders | |
| WO2017066712A3 (en) | Modulators of telomere disease | |
| BR112018008931A2 (pt) | ?compostos para tratamento de distúrbios hipoproliferativos? | |
| MX382488B (es) | Celulas madre neurales estables que comprenden un polinucleótido exógeno que codifica un factor de crecimiento y métodos de uso de las mismas. | |
| IL251616B (en) | Methods and compounds for the treatment and prevention of muscle mass loss | |
| SG10201804034QA (en) | Methods for treating hypotension | |
| UY35438A (es) | Procedimiento para preparar inhibidores de la glucosilceramida sintasa. | |
| WO2017066796A3 (en) | Modulators of telomere disease | |
| EA201592265A1 (ru) | Маркер для ассоциированных с кислой сфингомиелиназой нарушений и его применения | |
| BR112017011513A2 (pt) | tratamento de condições oculares usando células progenitoras | |
| CA2986376C (en) | Poxvirus-derived promoter, and vector comprising same | |
| EA201792603A1 (ru) | Ангиогенез с использованием стимулированных плацентарных стволовых клеток | |
| WO2015138761A3 (en) | Methods for treating peripheral nerve damage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |